Literature DB >> 15087383

Increased immunogenicity of colon cancer cells by selective depletion of cytochrome C.

Elise Schmitt1, Arnaud Parcellier, François Ghiringhelli, Noelia Casares, Sandeep Gurbuxani, Nathalie Droin, Ahmed Hamai, Marie Pequignot, Arlette Hammann, Monique Moutet, Annie Fromentin, Guido Kroemer, Eric Solary, Carmen Garrido.   

Abstract

We and others have previously reported in an in vivo rat colon cancer cell model that cell death precedes and is necessary for the development of a specific antitumoral immune response. To sensitize colon cancer cells to death, we depleted cytochrome c by stable transfection with an antisense construct. Cytochrome c depletion sensitizes human and rat colon cancer cells to a nonapoptotic, nonautophagic death induced by various stimuli. This increased sensitization to a necrosis-like cell death may be related to a decrease in cellular ATP levels and an increase in reactive oxygen species production caused by cytochrome c depletion. In vivo, depletion of cytochrome c decreases the tumorigenicity of colon cancer cells in syngeneic rats without influencing their growth in immune-deficient animals. Furthermore, decreased expression of cytochrome c in tumor cells facilitates in vivo "necrotic" cell death and the induction of a specific immune response. These results delineate a novel strategy to sensitize colon cancer cells to chemotherapy and to increase their immunogenicity in immuno-competent hosts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15087383     DOI: 10.1158/0008-5472.can-03-2475

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

Review 1.  Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.

Authors:  Nathalie Chaput; Stéphane De Botton; Michel Obeid; Lionel Apetoh; François Ghiringhelli; Theocharis Panaretakis; Caroline Flament; Laurence Zitvogel; Guido Kroemer
Journal:  J Mol Med (Berl)       Date:  2007-05-22       Impact factor: 4.599

Review 2.  Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy.

Authors:  H D González; J Figueras
Journal:  Clin Transl Oncol       Date:  2007-09       Impact factor: 3.405

3.  Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death.

Authors:  Noelia Casares; Marie O Pequignot; Antoine Tesniere; François Ghiringhelli; Stéphan Roux; Nathalie Chaput; Elise Schmitt; Ahmed Hamai; Sandra Hervas-Stubbs; Michel Obeid; Frédéric Coutant; Didier Métivier; Evelyne Pichard; Pierre Aucouturier; Gérard Pierron; Carmen Garrido; Laurence Zitvogel; Guido Kroemer
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

Review 4.  Antitumor immune responses mediated by dendritic cells: How signals derived from dying cancer cells drive antigen cross-presentation.

Authors:  Lotte Spel; Jaap-Jan Boelens; Stefan Nierkens; Marianne Boes
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

5.  Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas.

Authors:  Jae-Hong Ko; Wanjun Gu; Inja Lim; Tong Zhou; Hyoweon Bang
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

6.  Biogenic selenium nanoparticles produced by Lactobacillus casei ATCC 393 inhibit colon cancer cell growth in vitro and in vivo.

Authors:  Katerina Spyridopoulou; Eleni Tryfonopoulou; Georgios Aindelis; Petros Ypsilantis; Charalampos Sarafidis; Orestis Kalogirou; Katerina Chlichlia
Journal:  Nanoscale Adv       Date:  2021-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.